Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

278 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Efficacy of Mesenchymal Stem Cells for Radiation-Induced Xerostomia: A Randomized, Placebo-Controlled Phase 1/2 Trial (MESRIX).
Grønhøj C, Jensen DH, Vester-Glowinski P, Jensen SB, Bardow A, Oliveri RS, Fog LM, Specht L, Thomsen C, Darkner S, Jensen M, Müller V, Kiss K, Agander T, Andersen E, Fischer-Nielsen A, von Buchwald C. Grønhøj C, et al. Among authors: jensen dh, jensen m, jensen sb. Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):581-592. doi: 10.1016/j.ijrobp.2018.02.034. Epub 2018 Mar 6. Int J Radiat Oncol Biol Phys. 2018. PMID: 29678523 Clinical Trial.
Identifying sources and estimating glandular output of salivary TIMP-1.
Holten-Andersen L, Jensen SB, Bardow A, Harslund J, Thaysen-Andersen M, Lademann U, Usher PA, Offenberg H, Højrup P, Reibel J, Nielsen HJ, Brünner N, Nauntofte B. Holten-Andersen L, et al. Among authors: jensen sb. Scand J Clin Lab Invest. 2008;68(7):548-54. doi: 10.1080/00365510701883180. Scand J Clin Lab Invest. 2008. PMID: 18609089
A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life.
Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, Fulton JS, Jankovic L, Lopes NN, Mello AL, Muniz LV, Murdoch-Kinch CA, Nair RG, Napeñas JJ, Nogueira-Rodrigues A, Saunders D, Stirling B, von Bültzingslöwen I, Weikel DS, Elting LS, Spijkervet FK, Brennan MT; Salivary Gland Hypofunction/Xerostomia Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). Jensen SB, et al. Support Care Cancer. 2010 Aug;18(8):1039-60. doi: 10.1007/s00520-010-0827-8. Epub 2010 Mar 17. Support Care Cancer. 2010. PMID: 20237805 Review.
A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact.
Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, Fulton JS, Jankovic L, Lopes NN, Mello AL, Muniz LV, Murdoch-Kinch CA, Nair RG, Napeñas JJ, Nogueira-Rodrigues A, Saunders D, Stirling B, von Bültzingslöwen I, Weikel DS, Elting LS, Spijkervet FK, Brennan MT; Salivary Gland Hypofunction/Xerostomia Section; Oral Care Study Group; Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). Jensen SB, et al. Support Care Cancer. 2010 Aug;18(8):1061-79. doi: 10.1007/s00520-010-0837-6. Epub 2010 Mar 25. Support Care Cancer. 2010. PMID: 20333412 Review.
Does hyperbaric oxygen treatment have the potential to increase salivary flow rate and reduce xerostomia in previously irradiated head and neck cancer patients? A pilot study.
Forner L, Hyldegaard O, von Brockdorff AS, Specht L, Andersen E, Jansen EC, Hillerup S, Nauntofte B, Jensen SB. Forner L, et al. Among authors: jensen sb. Oral Oncol. 2011 Jun;47(6):546-51. doi: 10.1016/j.oraloncology.2011.03.021. Epub 2011 Apr 13. Oral Oncol. 2011. PMID: 21493124
278 results